Outcomes of pediatric patients supported with ventricular assist devices single center experience

Hsun-Yi Fu1, Heng-Wen Chou2, Chien-Heng Lai2

  • 1Department of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.

Insights

Pediatric ventricular assist device (VAD) use is increasing. Our hospital reports favorable outcomes for pediatric VAD patients, with 72.7% achieving positive results at one month.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Increasing use of pediatric ventricular assist devices (VADs) globally.
  • Limited participation of Asian pediatric heart centers in international VAD registries.
  • Need to report outcomes from non-Western centers.

Purpose of the Study:

  • To report the outcomes of pediatric VAD implantation at our institution.
  • To contribute data from an Asian pediatric heart center to the global understanding of VAD therapy.
  • To evaluate the safety and efficacy of VADs in a pediatric population.

Main Methods:

  • Retrospective analysis of all pediatric patients (<18 years) who received a VAD between 2008 and 2021.
  • Data collection on patient demographics, diagnosis, VAD type, INTERMACS profile, duration on support, and outcomes.
  • Analysis of survival rates, causes of death, and recovery status.

Main Results:

  • 33 pediatric patients received VADs, primarily for dilated cardiomyopathy (n=16) and acute fulminant myocarditis (n=9).
  • Paracorporeal continuous-flow pumps were most common (n=27), with most patients in INTERMACS profile 1 (n=24).
  • Positive outcomes (alive on device, bridge to transplantation/recovery) were observed in 72.7% at 1 month, 67.7% at 3 months, and 67.7% at 6 months. Neurological complications were the leading cause of death within the first month.

Conclusions:

  • Pediatric VAD implantation at our institution demonstrated favorable outcomes.
  • Early VAD support can be effective for critically ill pediatric heart failure patients.
  • Further research is needed to compare outcomes across different centers and VAD technologies.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
28
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
240
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
210
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25